{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:20:39Z","timestamp":1789903239174,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T00:00:00Z","timestamp":1313452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s11606-011-1828-0","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T09:47:40Z","timestamp":1313574460000},"page":"51-56","source":"Crossref","is-referenced-by-count":29,"title":["Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States"],"prefix":"10.1007","volume":"27","author":[{"given":"Pieter A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,16]]},"reference":[{"issue":"3","key":"1828_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999\u20132008. JAMA. 2010;303(3):235\u201341.","journal-title":"JAMA."},{"issue":"4","key":"1828_CR2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/oby.2007.136","volume":"16","author":"JL Pillitteri","year":"2008","unstructured":"Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: Results of a national survey. Obesity. 2008;16(4):790\u201396.","journal-title":"Obesity."},{"issue":"3","key":"1828_CR3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jada.2006.12.009","volume":"107","author":"HM Blanck","year":"2007","unstructured":"Blanck HM, Serdula MK, Gillespie C, et al. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc. 2007;107(3):441\u20137.","journal-title":"J Am Diet Assoc."},{"issue":"16","key":"1828_CR4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMp0904768","volume":"361","author":"PA Cohen","year":"2009","unstructured":"Cohen PA. American roulette\u2014contaminated dietary supplements. N Engl J Med. 2009;361(16):1523\u20135.","journal-title":"N Engl J Med."},{"issue":"2","key":"1828_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.2010.03822.x","volume":"71","author":"MH Tang","year":"2011","unstructured":"Tang MH, Chen SP, Ng SW, Chan AY, Mak TW. Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected. Br J of Pharmacol. 2011;71(2):250\u20133.","journal-title":"Br J of Pharmacol."},{"key":"1828_CR6","unstructured":"US Food and Drug Administration. Questions and Answers About FDA\u2019s Initiative Against Contaminated Weight Loss Products. [Internet]. Silver Spring, MD: Food and Drug Administration, Department of Drug Safety Information; [Updated 2011 Jan 27; Cited 2011 Aug 1]. Available from: http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/QuestionsAnswers\/ucm136187.htm"},{"key":"1828_CR7","unstructured":"US Food and Drug Administration. Tainted Products Marketed as Dietary Supplements; [Internet]. Silver Spring, MD: Food and Drug Administration, Department of Consumer Information; [Updated 2010 Dec 15; Cited 2011 Aug 1]. Available from: http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm236774.htm"},{"key":"1828_CR8","unstructured":"Medicine and Healthcare Products Regulatory Agency. Advice to consumers not to use Herbal Flos Lonicerae capsules (Herbal Xenicol); [Internet]. London, United Kingdom: Medicine and Healthcare Products Regulatory Agency, Department of Herbal Safety News; [Updated 2011 Feb 14; Cited 2011 Aug 1]. Available from: http:\/\/www.mhra.gov.uk\/Safetyinformation\/Generalsafetyinformationandadvice\/Herbalmedicines\/Herbalsafetyupdates\/Allherbalsafetyupdates\/CON108766"},{"key":"1828_CR9","unstructured":"US Food and Drug Administration. Pai You Guo, Marketed as Dietary Supplement-Recall; [Internet]. Silver Spring, MD: Food and Drug Administration, Department of Safety; [Updated 2009 Nov 13; Cited 2011 Aug 1]. Available from: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation%20\/SafetyAlertsforHumanMedicalProducts\/ucm190531.htm"},{"key":"1828_CR10","unstructured":"Medicine and Healthcare Products Regulatory Agency. Herbal product alert: Payouji (or Paiyouji) tea and Pai You Guo (Slim Capsules); [Internet]. London, United Kingdom: Medicine and Healthcare Products Regulatory Agency, Department of Herbal Safety News; [Updated 2010 Oct; Cited 2011 Aug 1]. Available from: http:\/\/www.mhra.gov.uk\/Howweregulate\/Medicines\/Herbalmedicines\/HerbalSafetyNews\/Currentsafetyissues\/CON094159"},{"key":"1828_CR11","unstructured":"Swiss Agency for Therapeutic Products. The trend continues: increases in imports of illegal medicines in Switzerland; [Internet]. Bern, Switzerland: Medicine and Healthcare Products Regulatory Agency, Department of Human Medicines; [Updated 2010 Sept 2; Cited 2011 Aug 1]. Available from: http:\/\/www.swissmedic.ch\/aktuell\/00003\/01205\/index.html?lang=en"},{"key":"1828_CR12","unstructured":"US Food and Drug Administration. Meridia (sibutramine hydrochloride) Information; [Internet]. Silver Spring, MD: Food and Drug Administration, Department of Drug Safety and Availability; [Updated 2008 Oct 10; Cited 2011 Aug 1]. Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm191652.htm"},{"key":"1828_CR13","unstructured":"US Food and Drug Administration. Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph. Notice of proposed rulemaking. Fed Regist. 1997 62(169):46223\u201326."},{"key":"1828_CR14","unstructured":"(Forensic Chemistry Center, US Food and Drug Administration, Cincinnati, OH). Conversation with: Pieter Cohen (Department of Internal Medicine, Cambridge Health Alliance, Somerville, MA). 2011 Apr 8."},{"key":"1828_CR15","unstructured":"(Westenberger BJ, Division of Pharmaceutical Analysis, US Food and Drug Administration, St. Louis, Missouri). Conversation with: Pieter Cohen (Department of Internal Medicine, Cambridge Health Alliance, Somerville, MA). 2011 May 3."},{"key":"1828_CR16","unstructured":"US Food and Drug Administration. Import Alert 66\u201341: Detention Without Physical Examination of Unapproved New Drugs Promoted in the U.S.; [Internet]. Silver Spring, MD: Food and Drug Administration, Import Program; [Updated 2011 Mar 11; Cited 2011 Aug 1]. Available from: http:\/\/www.accessdata.fda.gov\/cms_ia\/importalert_190.html"},{"key":"1828_CR17","unstructured":"Smith, Steve. Despite recall, diet pill still selling in Hub. Boston Globe [Internet]. 2010 May 31 [cited 2011 Aug 1]; News:[about 3 pages]. Available from: http:\/\/www.boston.com\/yourtown\/medford\/articles\/2010\/05\/31\/despite_recall_diet_pill_still_selling_in_hub\/"},{"issue":"3","key":"1828_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10903-007-9099-x","volume":"11","author":"PA Cohen","year":"2009","unstructured":"Cohen PA, McCormick D, Casey C, Dawson GF, Hacker KA. Imported compounded diet pill use among Brazilian women immigrants in the United States. J Immigr Minor Health. 2009;11(3):229\u201336.","journal-title":"J Immigr Minor Health."},{"key":"1828_CR19","unstructured":"World Health Organization. BMI Classification-Table 1, The International Classification of adult underweight, overweight and obesity according to BMI. [Internet]. Geneva, Switzerland: World Health Organization, Department of Data and Statistics; [Updated 2011 Apr 16; cited 2011 Aug 1]. Available from: http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.html"},{"issue":"10","key":"1828_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363(10):905.","journal-title":"N Engl J Med"},{"issue":"4","key":"1828_CR21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1467-789X.2007.00425.x","volume":"9","author":"M Florentin","year":"2008","unstructured":"Florentin M, Liberopoulos EN, Elisaf MS. Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev. 2008;9(4):378\u201387.","journal-title":"Obes Rev."},{"issue":"12","key":"1828_CR22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4065\/81.12.1627","volume":"81","author":"MH Nguyen","year":"2006","unstructured":"Nguyen MH, Ormiston T, Kurani S, Woo DK. Amphetamine lacing of an Internet-marketed neutraceutical. Mayo Clin Proc. 2006;81(12):1627\u20139.","journal-title":"Mayo Clin Proc."},{"issue":"3","key":"1828_CR23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11606-008-0878-4","volume":"24","author":"PA Cohen","year":"2009","unstructured":"Cohen PA. Imported fenproporex-based diet pills from Brazil: a report of two cases. J Gen Intern Med. 2009;24(3):430\u20133.","journal-title":"J Gen Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-011-1828-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-011-1828-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-011-1828-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:45:38Z","timestamp":1559396738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-011-1828-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,16]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1007\/s11606-011-1828-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,16]]}}}